Accessibility Menu
Covalon Technologies logo

Covalon Technologies(OTC) CVALF

Market Cap$42.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)+175%
5 Year+38%
1 Year-14%
1 Month+0%
$1.55
+0.65%
+0.01Today
Covalon Technologies last closing stock price
MetricPriceDate
Last closeUSD 1.552026-07-27
Covalon Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.31%USD 1.532026-07-20
1 month+0%USD 1.552026-06-26
3 month+11.11%USD 1.402026-04-28
Year to date+25%USD 1.242025-12-31
1 year-13.92%USD 1.802025-07-25
3 year+19.52%USD 1.302023-07-27
5 year+38.44%USD 1.122021-07-27
Since inception+175.14%USD 0.562012-10-24

Covalon Technologies Financials at a Glance

Market Cap

$42.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$32.70M

Net Income (TTM)

CA$1.64M

EPS (TTM)

$0.04

P/E Ratio

35.80

Dividend

$0.00

Beta (Volatility)

0.08 (Low)

Price

$1.55

Volume

1,200

Open

$1.55

Previous Close

$1.55

Daily Range

$1.55 - $1.57

52-Week Range

$1.16 - $2.00

Estimated Earnings Date

Aug 20, 2026

CVALF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Covalon Technologies

Covalon Technologies Ltd. is a global medical technology firm specializing in innovative medical solutions. The company focuses on the production, commercialization, and licensing of advanced medical products across various regions, including North America, Europe, and Asia.

Products and Services
  • Wound care dressings for chronic and infected wounds
  • Antimicrobial silicone adhesive products for surgical applications
  • Advanced medical coatings for medical devices
Growth Outlook
  • Recent quarterly revenue reached $8.75 million, a significant increase
  • Trailing twelve months (TTM) revenue shows a growth trend
  • Strong demand for innovative medical solutions supports future expansion
Financial Highlights
  • TTM revenue of $30.5 million reflects robust market performance
  • Net income for the latest quarter was $1.1 million, indicating profitability
  • Current ratio of 7.57 suggests strong liquidity position
Covalon Technologies Ltd. operates within the biotechnology sector, leveraging three proprietary technological platforms to address critical healthcare needs. The company's focus on wound care and infection management positions it well in a growing market, driven by an increasing demand for effective medical solutions. Recent financial performance indicates a positive trajectory, with notable revenue growth and profitability in the latest quarter. The strong liquidity position further enhances the company's ability to invest in research and development, ensuring continued innovation and market competitiveness.
AI Generated • Jul 24, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Brent Ashton

Website

www.covalon.com

Headquarters

Mississauga, ON L4W 5S7, CA

CVALF Financials

Key Financial Metrics (TTM)

Gross Margin

52.96%

Operating Margin

3.49%

Net Income Margin

5.02%

Return on Equity

5.72%

Return on Capital

5.35%

Return on Assets

4.95%

Earnings Yield

2.79%

Dividend Yield

0.00%

Payout Ratio

2.52%

Stock Overview

Market Cap

$42.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

27.62M

Volume

1.20K

Avg. Volume

5.97K

Financials (TTM)

Gross Profit

CA$17.32M

Operating Income

CA$1.14M

EBITDA

CA$2.09M

Operating Cash Flow

CA$6.27M

Capital Expenditure

-CA$1.35M

Free Cash Flow

CA$4.92M

Cash & ST Invst.

CA$16.61M

Total Debt

CA$1.78M

Covalon Technologies Performance Analysis

Covalon Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30CAD 14,203,326-8.2%
20232023-09-30CAD 19,718,06338.8%
20242024-09-30CAD 22,904,33316.2%
20252025-09-30CAD 23,471,5102.5%
Covalon Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-3010.4%
Q42025-09-303.8%
Q12025-12-31-20.8%
Q22026-03-3127.1%
Covalon Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30CAD -0.29N/A
20232023-09-30CAD -0.13-54.7%
20242024-09-30CAD 0.08N/A
20252025-09-30CAD 0.05-32.8%
Covalon Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-88.5%
Q42025-09-30469.6%
Q12025-12-31-65.6%
Q22026-03-31777.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$8.75M

+15.3%

Gross Profit

CA$5.17M

+25.0%

Gross Margin

59.14%

N/A

Market Cap

$42.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$407.70K

N/A

Employees

105

N/A

Net Income

CA$1.10M

+155.5%

EBITDA

CA$1.17M

+126.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$16.61M

-7.9%

Total Debt

CA$1.78M

+191.8%

Accounts Receivable

CA$4.71M

-6.2%

Inventory

CA$6.39M

-28.4%

Long Term Debt

CA$1.45M

+1209.7%

Short Term Debt

CA$664.91K

+33.2%

Return on Assets

4.95%

N/A

Return on Invested Capital

3.87%

N/A

Free Cash Flow

-CA$1.33M

-306.6%

Operating Cash Flow

-CA$1.15M

-271.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACHFFArch Biopartners Inc.
$0.58+4.90%
SEOVFSernova Corp.
$0.09+12.50%
INNMFAmplia Therapeutics Limited
$0.11+0.00%
MMIRFMedMira Inc.
$0.04+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%

Questions About CVALF

What is the current price of Covalon Technologies?

Covalon Technologies is trading at $1.55 per share.

What is the 52-week range for Covalon Technologies?

Over the past 52 weeks, Covalon Technologies has traded between $1.16 and $2.00.

How much debt does Covalon Technologies have?

As of the most recent reporting period, Covalon Technologies reported total debt of CA$1.27M.

How much cash does Covalon Technologies have on hand?

Covalon Technologies reported CA$11.87M in cash and cash equivalents in its most recent financial results.

What is Covalon Technologies’s dividend yield?

Covalon Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services